NCI-N87 Cells

NCI-N87, also known as N87, is a human gastric cancer cell line and is widely utilized in cancer research, particularly gastric carcinoma studies. NCI-N87 cells contribute to our understanding of the digestion model of the gastric mucosa and play a role in the development of gastroretentive delivery systems. In pharmacological contexts, NCI-N87 cells have been used to explore the role of gentamicin as an anticancer agent. The gastric adenocarcinoma cell line NCI-N87 is tumorigenic and expresses the oncogenes myc and erb-B2, and are therefore instrumental in xenograft model studies. This cell line's inflammatory properties and response to agents like gentamicin can be assayed, as can its potential involvement in epithelial barrier integrity and function using intestinal permeability assays. The cells are known to express surface glycoproteins such as carcinoembryonic antigen (CEA) and TAG 72, but are negative for L-dopa decarboxylase (DDC). The cells show minimal positivity for vasoactive intestinal peptide (VIP) receptors and lack gastrin receptors, and they express receptors for muscarinic cholinergic agents. No amplification or rearrangements were observed in N-myc, L-myc, myb, and EGF receptor genes in these cells. In summary, the gastric epithelium cell line NCI-N87 serves as a model for gastric cancer research, epithelial cell behavior, drug delivery systems, and the metabolic pathways of nutritionally relevant compounds.